Research Radar — 2026-05-23
Methods & AI
Computational
Scaffold-Lab: Critical Evaluation and Ranking of Protein Backbone Generation Methods in a Unified Framework
PLOS Computational Biology Published 2026-05-22 research article DOI: 10.1371/journal.pcbi.1014290
protein design benchmarking backbone generation deep learning diffusion models structure prediction evaluation framework
Summary: Introduces Scaffold-Lab, a comprehensive and unified benchmarking framework for critically evaluating and ranking protein backbone generation methods. The framework systematically compares state-of-the-art deep learning and physics-based approaches — including diffusion models, flow matching, and GAN-based generators — across multiple metrics capturing designability, novelty, diversity, and structural plausibility. Crucially, Scaffold-Lab reveals that no single method dominates across all metrics, and that commonly reported metrics can be misleading when evaluated in isolation. The framework provides standardized data splits, evaluation protocols, and visualization tools, establishing a community benchmark for the rapidly expanding field of computational protein backbone design.
Why it matters: The field of protein backbone generation has exploded with new methods published monthly, yet comparative evaluation remains ad hoc and metric selection is often cherry-picked. Scaffold-Lab provides the first systematic, multi-metric evaluation framework analogous to CASP for structure prediction — essential for identifying which methods actually generalize and for guiding the field toward genuinely improved design algorithms rather than benchmark overfitting.
Why for Yiru: Protein design is directly relevant to therapeutic development, including engineered binders for TME targets and de novo enzymes for cancer metabolism intervention. A rigorous benchmarking framework helps separate genuine advances from incremental tweaks, informing which tools to adopt for real-world protein engineering challenges.
AI-Guided Redesign of Laboratory-Evolved Reverse Transcriptases Enhances Prime Editing
Nature Biotechnology Published 2026-05-21 research article DOI: 10.1038/s41587-026-03149-6
prime editing reverse transcriptase protein engineering machine learning directed evolution gene editing CRISPR
Summary: Reports AI-guided redesign of laboratory-evolved reverse transcriptases (RTs) to enhance prime editing efficiency. The study combines directed evolution data with machine learning models to predict mutations that improve RT processivity, fidelity, and compatibility with prime editing guide RNAs (pegRNAs). The ML-guided variants substantially outperform parental RTs across multiple genomic loci and editing types, achieving higher precise editing rates with reduced indel byproducts. This work demonstrates a generalizable pipeline for computationally accelerating the optimization of gene-editing enzymes beyond what traditional directed evolution alone can achieve.
Why it matters: Prime editing enables precise genome modifications without double-strand breaks, but its efficiency remains limiting for therapeutic applications. ML-guided enzyme optimization represents a paradigm shift from blind mutagenesis to predictive protein engineering, potentially accelerating the development of clinical-grade prime editors for genetic disease correction and cancer cell engineering.
Why for Yiru: Gene editing tools are foundational for functional genomics in cancer research — from generating isogenic cell lines to engineering CAR-T cells. Improved prime editing efficiency directly enables more sophisticated genetic perturbation experiments in TME-relevant models, including multiplexed editing of immune checkpoint and metabolic genes.
PATTY Corrects Open-Chromatin Bias for Improved Bulk and Single-Cell CUT&Tag Profiling
Nature Communications Published 2026-05-22 research article DOI: 10.1038/s41467-026-73599-8
CUT&Tag chromatin epigenomics single-cell bias correction computational method open chromatin
Summary: Presents PATTY, a computational method that corrects for open-chromatin bias in both bulk and single-cell CUT&Tag (Cleavage Under Targets and Tagmentation) profiling. CUT&Tag has emerged as a powerful alternative to ChIP-seq for mapping histone modifications and chromatin-associated proteins, but the Tn5 transposase used in the protocol preferentially inserts into accessible chromatin regions, introducing systematic bias that conflates genuine enrichment with chromatin accessibility. PATTY models and corrects for this accessibility-dependent bias using ATAC-seq or DNA accessibility information, substantially improving the accuracy of CUT&Tag-based epigenomic maps in both bulk and single-cell modalities.
Why it matters: CUT&Tag is rapidly replacing ChIP-seq for epigenomic profiling due to its lower cell input requirements and simpler workflow, but the open-chromatin bias problem has been underappreciated. PATTY provides an essential correction that improves the biological interpretability of CUT&Tag data, particularly important as single-cell epigenomic atlases are being generated across cancer types and developmental systems.
Why for Yiru: Epigenomic profiling is critical for understanding gene regulatory programs in the TME, including how immune cells adopt suppressive phenotypes and how tumour cells evolve drug tolerance. Accurate CUT&Tag analysis with bias correction ensures that histone modification patterns attributed to biological differences are not confounded by technical artifacts from chromatin accessibility variation.
A Scalable Tn5-Based Method for Genome-Wide DNA Methylation Profiling in Development and Disease
Nature Communications Published 2026-05-22 research article DOI: 10.1038/s41467-026-73325-4
DNA methylation epigenetics Tn5 CUT&Tag method development cancer biomarker single-cell
Summary: Develops CmeCUT&Tag, a Tn5-based approach that uses methylation-binding domain (MBD) fusion proteins to selectively target methylated DNA in both chromatinized and isolated DNA samples for genome-wide methylation profiling. Unlike bisulfite sequencing which requires high sequencing depth and suffers from DNA degradation, CmeCUT&Tag achieves targeted enrichment of methylated regions with lower input requirements and simplified library preparation. The method is demonstrated across developmental stages and disease contexts including cancer, where DNA methylation patterns serve as diagnostic and prognostic biomarkers. The scalability of the approach makes it compatible with single-cell and low-input applications.
Why it matters: DNA methylation is a cornerstone epigenetic mark in cancer biology — from tumour suppressor silencing to immune evasion and drug resistance. A scalable, low-input methylation profiling method that bypasses the limitations of bisulfite sequencing could democratize epigenomic profiling in clinical samples and enable methylation-based liquid biopsy with substantially reduced cost and turnaround time.
Why for Yiru: DNA methylation profiling in the TME context can reveal how stromal and immune cells are epigenetically reprogrammed, complementing transcriptomic and chromatin accessibility data. A method compatible with low-input clinical samples is directly relevant to translational TME studies where sample quantity is limiting.
Accurate, Scalable and Cross-Platform Cell Identification for High-Resolution Spatial Transcriptomics
Nature Genetics Published 2026-05-20 research article DOI: 10.1038/s41588-026-02610-1
spatial transcriptomics cell identification cross-platform deep learning computational method tissue analysis
Summary: Presents a computational framework for accurate, scalable, and cross-platform cell identification in high-resolution spatial transcriptomics data. As spatial transcriptomics technologies proliferate (Visium HD, MERFISH, Xenium, CosMx, Stereo-seq) with varying resolution, chemistry, and data characteristics, cell segmentation and type identification have become a major bottleneck. The method achieves robust cell identification across platforms by leveraging self-supervised learning on spatial gene expression patterns combined with morphological cues, enabling consistent cell-type annotations regardless of the underlying technology. Demonstrated on multiple tissue types and platforms.
Why it matters: The spatial transcriptomics field faces a fragmentation problem where each platform produces data with distinct characteristics, making cross-study comparisons difficult. A platform-agnostic cell identification method is essential for building unified spatial atlases and for translating findings between discovery platforms and clinical-grade assays.
Why for Yiru: Spatial transcriptomics is central to TME research — understanding how tumour, immune, and stromal cells organize in space is directly relevant to immunotherapy response and resistance. A cross-platform cell identification framework enables integration of spatial data across technologies, maximizing the value of spatial TME studies regardless of which platform was used.
Interpretable Deep Learning Framework for Mapping E3–Substrate Binding Interfaces
Nature Communications Published 2026-05-20 research article DOI: 10.1038/s41467-026-73440-2
deep learning protein-protein interaction ubiquitination E3 ligase interpretable AI computational biology
Summary: Develops an interpretable deep learning framework for mapping the binding interfaces between E3 ubiquitin ligases and their substrate proteins. E3 ligases determine substrate specificity in the ubiquitin-proteasome system, yet predicting which E3 targets which substrate — and through which interface — remains a fundamental challenge. The framework combines structure-informed attention mechanisms with explainable AI techniques to identify critical interface residues, validated against experimentally determined E3–substrate complex structures. The model generalizes to E3 ligase families beyond those in the training set, suggesting it captures general principles of E3–substrate recognition.
Why it matters: The ubiquitin-proteasome system regulates virtually every cellular process, and E3 ligase dysregulation is implicated in cancer, neurodegeneration, and immune disorders. Targeted protein degradation (PROTACs, molecular glues) relies on hijacking E3 ligases — knowing which E3–substrate interfaces are druggable and predictable dramatically accelerates degrader drug discovery.
Why for Yiru: Ubiquitin-mediated protein degradation is a key regulatory mechanism in the TME, controlling immune checkpoint protein turnover, transcription factor stability, and stress responses. Mapping E3–substrate interactions computationally could reveal novel regulatory nodes in tumour and immune cells amenable to therapeutic intervention.
Biomedical discoveries
Biomedicine
Macrophage-Derived Fibronectin Suppresses Antitumor Immunity via Tissue Stiffening and Immunosuppressive Cell Induction in Cancer Mouse Models
Nature Communications Published 2026-05-22 research article DOI: 10.1038/s41467-026-73287-7
tumor-associated macrophage fibronectin tissue stiffness immunosuppression ECM remodeling NSCLC immunotherapy
Summary: Reveals a mechanical immunosuppression axis in non-small cell lung cancer (NSCLC) driven by tumor-associated macrophages (TAMs). Using single-cell transcriptomics of primary NSCLC samples, the authors show that TAMs are a major source of the extracellular matrix component fibronectin. Macrophage-derived fibronectin increases tumor tissue stiffness through ECM remodeling, which in turn promotes the recruitment and induction of immunosuppressive cell populations while suppressing antitumor T-cell function. This establishes a bidirectional feed-forward loop: TAMs stiffen the tumor microenvironment, and increased stiffness further shapes an immunosuppressive niche. Therapeutically, disrupting fibronectin deposition or targeting mechanosensitive pathways partially restores immunotherapy response in preclinical models.
Why it matters: Tumor stiffness has long been recognized as a physical hallmark of cancer with prognostic value, but its mechanistic link to immunosuppression has been unclear. This study identifies macrophage-derived fibronectin as the molecular bridge connecting TAMs, tissue mechanics, and immune evasion — opening a new therapeutic axis for combining ECM-targeting agents with checkpoint immunotherapy. The finding that mechanical signals directly suppress antitumor immunity adds a physical dimension to TME biology.
Why for Yiru: This paper is directly at the intersection of TME biology and immunotherapy. It mechanistically connects two phenomena central to Boss's interests — TAM-mediated immunosuppression and ECM remodeling — through a specific molecular mediator (fibronectin) and a measurable physical property (tissue stiffness). The concept of 'mechanical checkpoint blockade' is a frontier concept with translational potential.
Inhibition of Salt-Inducible Kinases Reprograms T Cells and Antitumor Immunity in Ovarian Cancer
Nature Immunology Published 2026-05-20 research article DOI: 10.1038/s41590-026-02512-8
salt-inducible kinase T cell immunotherapy ovarian cancer metabolic reprogramming tumor immunity SIK inhibitor
Summary: Demonstrates that pharmacological inhibition of salt-inducible kinases (SIKs) reprograms T cells to enhance antitumor immunity, specifically in ovarian cancer models. SIKs are metabolic sensors that restrain T-cell effector function under nutrient-limited conditions. SIK inhibition relieves this metabolic checkpoint, promoting T-cell mitochondrial fitness, cytokine production, and cytotoxic activity even within the metabolite-depleted ovarian TME. In preclinical ovarian cancer models, SIK inhibitor treatment synergizes with checkpoint blockade to achieve durable tumor control. The study provides mechanistic insight connecting cellular metabolism, epigenetic regulation, and T-cell effector differentiation in the context of a notoriously immunotherapy-resistant cancer.
Why it matters: Ovarian cancer has been largely refractory to checkpoint immunotherapy, partly due to the metabolically hostile TME that impairs T-cell function. SIK inhibition represents a metabolic reprogramming strategy — rather than blocking inhibitory receptors, it enhances T-cell fitness to function despite suppressive conditions. This opens a new class of immunotherapy targets (metabolic kinases) for cancers where conventional checkpoint blockade fails.
Why for Yiru: Metabolic regulation of T-cell function in the TME is a rapidly emerging area. The concept of 'metabolic checkpoint blockade' — enhancing T-cell fitness rather than removing inhibitory signals — is complementary to existing immunotherapy strategies and may be particularly relevant in metabolically challenging TMEs like ovarian cancer, pancreatic cancer, and others.
Use of Circulating Tumour DNA to Prospectively Guide a Switch from Targeted to Immune Therapy in BRAF Mutant Advanced Melanoma
Nature Communications Published 2026-05-21 research article DOI: 10.1038/s41467-026-73518-z
ctDNA liquid biopsy BRAF melanoma immunotherapy targeted therapy adaptive trial precision oncology
Summary: Reports a prospective clinical study using circulating tumour DNA (ctDNA) dynamics to guide the therapeutic switch from BRAF/MEK-targeted therapy to checkpoint inhibitor immunotherapy in BRAF-mutant advanced melanoma. Patients are monitored with serial ctDNA measurements during targeted therapy; those with rising ctDNA (indicating emerging resistance) are switched early to immunotherapy before radiographic progression occurs. The ctDNA-guided adaptive strategy demonstrates improved outcomes compared to conventional radiographically triggered switching, with ctDNA dynamics providing a lead time of weeks to months over imaging. The study establishes ctDNA as a real-time, actionable biomarker for adaptive therapeutic sequencing in melanoma.
Why it matters: The optimal sequencing of targeted therapy and immunotherapy in BRAF-mutant melanoma remains a critical clinical question. Using ctDNA as an early molecular signal of resistance enables proactive treatment switching before clinical deterioration — a paradigm shift from waiting for scans to show progression. This adaptive strategy could maximize the therapeutic window for both modalities and is generalizable to other cancers where targeted therapy and immunotherapy are both options.
Why for Yiru: ctDNA-based monitoring and adaptive therapy represent the frontier of precision oncology. The concept of using molecular dynamics rather than radiographic progression to guide treatment decisions is directly relevant to understanding TME evolution under therapeutic pressure and to developing biomarkers for immunotherapy response.
Distinct Genomic and Immunologic Tumor Evolution in Germline TP53-Driven Breast Cancers
Nature Communications Published 2026-05-21 research article DOI: 10.1038/s41467-026-73514-3
TP53 germline mutation breast cancer tumor evolution immunogenomics Li-Fraumeni neoantigen
Summary: Characterizes the distinct genomic and immunologic evolutionary trajectories of breast cancers arising in carriers of pathogenic germline TP53 mutations (Li-Fraumeni syndrome) versus sporadic TP53-mutant tumours. Using multi-region whole-genome sequencing and immune profiling, the study reveals that germline TP53-driven tumours exhibit a fundamentally different evolutionary pattern: earlier whole-genome doubling, distinct mutational signatures, and a unique immunoediting landscape. Germline TP53 tumours show evidence of stronger immune selection with distinct neoantigen depletion patterns, suggesting that constitutive p53 deficiency from the first cell shapes both the genomic landscape and the immunologic relationship between tumour and host in ways distinct from somatically acquired p53 loss.
Why it matters: Understanding how germline cancer predisposition shapes tumor evolution informs surveillance, prevention, and therapeutic strategies. The finding that germline TP53 tumours have a distinct immunologic evolutionary trajectory suggests that immunotherapy approaches may need to be tailored differently for hereditary versus sporadic cancers — a consideration not currently factored into clinical trial designs.
Why for Yiru: The intersection of germline genetics, tumour evolution, and anti-tumour immunity is a frontier area. Understanding how constitutive p53 deficiency shapes the immunogenicity of evolving tumours from the very first transformed cell provides insights into immune editing that are directly relevant to TME biology and cancer immunology.
Directed Evolution of Small RNA-Stabilizing Motifs That Improve Prime-Editing Efficiency
Nature Biotechnology Published 2026-05-20 research article DOI: 10.1038/s41587-026-03123-2
prime editing directed evolution RNA stability pegRNA gene editing CRISPR protein engineering
Summary: Reports the directed evolution of small RNA-stabilizing structural motifs that substantially improve prime-editing efficiency when incorporated into prime editing guide RNAs (pegRNAs). pegRNAs are longer and more structurally complex than standard sgRNAs, making them susceptible to degradation and misfolding. Through systematic evolution of RNA structural elements, the authors identify compact motifs that protect pegRNAs from exonucleolytic degradation while preserving their ability to template the desired edit. The evolved motifs improve prime editing across diverse genomic loci and cell types, addressing one of the key bottlenecks in prime editing efficiency.
Why it matters: Prime editing holds enormous therapeutic promise but is limited by pegRNA stability and expression. RNA-stabilizing motifs that are small enough to be incorporated into existing delivery vectors provide a practical, immediately deployable solution. Combined with the AI-guided reverse transcriptase optimization (computational article #2), this work represents converging progress on both the protein and RNA components of the prime editing system.
Why for Yiru: Gene editing tools are essential for cancer research — from modeling tumour suppressor loss to engineering immunotherapy cells. Improved prime editing directly accelerates the generation of precise disease models and therapeutic cell products, with relevance to TME-focused functional genomics.
Non-Mendelian Inheritance of DNA Methylation Patterns in Mice
Nature Genetics Published 2026-05-20 research article DOI: 10.1038/s41588-026-02604-z
DNA methylation epigenetics non-Mendelian inheritance transgenerational mouse genetics epimutation
Summary: Reports the discovery of non-Mendelian inheritance patterns of DNA methylation in mice, where methylation states at specific loci are transmitted across generations in patterns that deviate from classical Mendelian expectations. Using multi-generational pedigrees and whole-genome bisulfite sequencing, the authors identify loci where methylation patterns are influenced by parental origin, genetic background interactions, or persist through meiosis despite sequence-independent mechanisms. The study provides some of the strongest evidence to date for transgenerational epigenetic inheritance in mammals, challenging the assumption that the epigenome is completely reset between generations.
Why it matters: The possibility of transgenerational epigenetic inheritance in mammals has been highly controversial. Robust evidence for non-Mendelian methylation inheritance would fundamentally expand our understanding of heritability — beyond DNA sequence — with implications for how we think about disease risk, environmental exposures, and evolutionary adaptation. If epigenetic states can be inherited, parental experiences could shape offspring phenotypes through mechanisms beyond genetics.
Why for Yiru: Epigenetic regulation is central to cancer biology — from tumour suppressor silencing to immune evasion. If methylation patterns can be transmitted across generations, it opens questions about whether cancer-relevant epigenetic states (e.g., at tumour suppressor loci) could have transgenerational dimensions, and more broadly how epigenetic memory operates in somatic tissues including the TME.
Cross-disciplinary watchlist
Other Fields
A Multimodal Adaptive Optical Microscope for In Vivo Imaging from Molecules to Organisms
Nature Methods Published 2026-05-22 research article DOI: 10.1038/s41592-026-03066-1
microscopy adaptive optics in vivo imaging multimodal multiscale fluorescence deep tissue imaging
Summary: Presents a multimodal adaptive optical microscope capable of in vivo imaging across an unprecedented range of spatial and temporal scales — from single molecules to whole organisms. The system integrates adaptive optics to correct for sample-induced aberrations in real time, enabling high-resolution imaging deep within living tissues across multiple modalities including confocal, two-photon, light-sheet, and super-resolution modes. Demonstrations span molecular tracking of single proteins in cells, volumetric imaging of neural circuits in the mouse brain, and developmental imaging of whole zebrafish embryos over days. The platform addresses the fundamental tradeoff between imaging depth, resolution, and field of view that has limited comprehensive in vivo studies.
Why it matters: The ability to seamlessly image biological processes from the molecular to organismal scale within the same instrument represents a paradigm shift in microscopy. By correcting aberrations that degrade image quality in living tissue, adaptive optics enables long-term, high-resolution observation of dynamic processes in their native context — essential for studies of development, neuroscience, immunology, and cancer biology that span multiple spatial scales.
Why for Yiru: Advanced microscopy is essential for TME research — from tracking individual immune cells interacting with tumour cells to visualizing ECM architecture and drug distribution. A platform that spans molecular to organismal imaging with adaptive aberration correction could enable new classes of TME observations, including deep-tissue imaging of immune-tumour interactions in their native 3D context.
Structural Basis of Signal Peptide Recognition by the Signal Peptidase Complex
Nature Communications Published 2026-05-22 research article DOI: 10.1038/s41467-026-73423-3
structural biology cryo-EM signal peptidase protein translocation ER membrane protein secretory pathway
Summary: Presents a 2.6 Å cryo-EM structure of the human signal peptidase complex (SPC-A), revealing the molecular basis for how this essential enzyme recognizes and cleaves signal peptides from approximately 10% of the human proteome. Signal peptides share only general chemical properties (hydrophobic h-region, polar c-region) rather than sequence conservation, making the SPC's exquisite specificity a long-standing biochemical puzzle. The structure reveals how the SPC catalytic site accommodates diverse signal peptide sequences through a combination of shape complementarity, hydrophobic packing, and conformational plasticity. The work provides a structural framework for understanding ER translocation, a fundamental process in eukaryotic cell biology.
Why it matters: The secretory pathway processes a vast fraction of the proteome including virtually all membrane proteins, secreted factors, and immune receptors. Understanding signal peptide recognition at atomic resolution has implications for predicting protein localization, engineering secreted therapeutics, and understanding diseases caused by translocation defects. The SPC is also an under-explored therapeutic target — its structure enables rational drug design.
Why for Yiru: Protein secretion and membrane protein biogenesis are relevant to TME biology through cytokine/chemokine secretion, immune receptor trafficking, and surface antigen presentation. Understanding the molecular machinery that controls which proteins enter the secretory pathway connects to how tumour and immune cells regulate their surface proteomes and secreted factors.
Semaglutide versus Placebo in Individuals with Poor Weight Loss After Bariatric Surgery: A Double-Blinded, Randomized Trial
Nature Medicine Published 2026-05-22 research article DOI: 10.1038/s41591-026-04416-4
semaglutide GLP-1 bariatric surgery obesity randomized controlled trial metabolism weight loss
Summary: Reports results from BARI-STEP, a double-blinded, randomized, placebo-controlled trial evaluating semaglutide 2.4 mg weekly in adults with suboptimal weight loss (less than 20% from surgery) at least one year after gastric bypass or sleeve gastrectomy. The trial, conducted as an adjunct to lifestyle intervention, demonstrates that semaglutide produces significant additional weight loss compared to placebo in this post-bariatric population. Secondary outcomes include improvements in cardiometabolic risk factors and quality of life. This addresses the clinically important problem of weight regain or insufficient weight loss after bariatric surgery, which affects a substantial fraction of patients.
Why it matters: With the explosive adoption of GLP-1 receptor agonists for obesity management, understanding their role in complex patient populations — including post-bariatric surgery patients — is essential for evidence-based practice. This trial provides the first randomized evidence that pharmacological GLP-1 agonism can salvage insufficient surgical weight loss, potentially changing the standard of care for post-bariatric patients.
Why for Yiru: Obesity is a major risk factor for multiple cancers and shapes the systemic metabolic environment that influences the TME. Understanding how metabolic interventions like GLP-1 agonists interact with surgical weight loss has implications for cancer prevention and for how systemic metabolism modulates tumour biology and immunotherapy response.
Mapping Where Mouse Models Match — and Miss — Human Tumor Immunity
Nature Immunology Published 2026-05-21 review DOI: 10.1038/s41590-026-02527-1
mouse models tumor immunity translational research immunotherapy preclinical models human immunology
Summary: Provides a comprehensive analysis mapping where commonly used mouse tumour models faithfully recapitulate human antitumor immunity — and critically, where they diverge. The review systematically compares immune composition, checkpoint molecule expression, mutational burden, and immunotherapy response patterns between mouse models (syngeneic, genetically engineered, and humanized) and human cancers across multiple tumour types. Key findings include systematic divergences in innate immune compartments, differences in the timing of immune infiltration relative to tumour development, and species-specific aspects of checkpoint biology that affect translational predictivity. The article provides practical guidance for model selection based on the specific immunotherapy question being asked.
Why it matters: The translational gap between preclinical immunotherapy studies and clinical trial outcomes remains a major challenge in cancer drug development. A systematic map of where mouse models succeed and fail in recapitulating human tumour immunity is essential for interpreting preclinical results and for designing models that better predict clinical outcomes. This review serves as a field-wide reference for model selection.
Why for Yiru: Choosing the right preclinical model is fundamental to TME research. Understanding which aspects of human tumour immunity are faithfully represented in which mouse models directly impacts experimental design and the translational relevance of TME discoveries — particularly when studying immunotherapy responses in the TME context.
Observation of Quantum Vortex Core Fractionalization and Skyrmion Formation in a Superconductor
Science Published 2026-05-21 research article DOI: 10.1126/science.ads0189
quantum physics superconductivity vortex skyrmion topological matter condensed matter physics
Summary: Reports the first experimental observation of quantum vortex core fractionalization and skyrmion formation in a superconducting material. Using scanning tunneling microscopy and spectroscopy at millikelvin temperatures, the authors directly visualize how magnetic vortices in a topological superconductor can split their cores into fractional components that form skyrmion textures — topologically protected spin configurations. This phenomenon, previously predicted theoretically but never observed, represents a new quantum phase at the intersection of superconductivity and topology, with implications for topological quantum computing where vortex-skyrmion states could serve as protected qubits.
Why it matters: Topological superconductors are a leading platform for fault-tolerant quantum computing because their exotic quasiparticles (Majorana modes) are inherently protected from decoherence. The observation of vortex core fractionalization provides experimental evidence for the topological nature of the superconducting state and opens a new route to controlling topological defects for quantum information processing.
Why for Yiru: While this is fundamental condensed matter physics rather than biomedicine, the conceptual frameworks of topology and protected states have interesting parallels in biological systems — from topologically associating domains in genomes to robust signalling networks. Understanding how nature achieves fault tolerance through topology is a cross-disciplinary concept with broad intellectual value.
FERONIA Orchestrates Plasma Membrane Nanoclusters for Plant Thermotolerance
Science Published 2026-05-21 research article DOI: 10.1126/science.aeb1752
plant biology thermotolerance membrane nanodomains FERONIA signaling climate adaptation
Summary: Reveals that the plant receptor kinase FERONIA orchestrates the formation of plasma membrane nanoclusters that confer thermotolerance in plants. Under heat stress, FERONIA reorganizes membrane lipid and protein components into functional nanodomains that stabilize membrane integrity and coordinate heat-shock signaling. Disruption of FERONIA-mediated nanoclustering abolishes thermotolerance, while enhancing FERONIA activity improves heat resistance. The study connects membrane biophysics, receptor signaling, and organismal stress adaptation, identifying a molecular mechanism by which plants sense and survive elevated temperatures — a trait of increasing agricultural importance under climate change.
Why it matters: Heat stress is one of the most significant threats to global agriculture under climate change, reducing crop yields worldwide. Understanding the molecular basis of thermotolerance — particularly a tunable receptor kinase pathway — opens possibilities for engineering heat-resistant crops through breeding or biotechnology. The concept of membrane nanodomains as signaling platforms is also broadly relevant across kingdoms.
Why for Yiru: The organization of plasma membrane signaling into functional nanodomains has conceptual parallels in immune cell activation, where receptor clustering in membrane microdomains (immune synapses, lipid rafts) is essential for signaling. Understanding how membrane organization enables robust stress responses in plants may inform how membrane-based signaling operates in stress-exposed cells in the TME.